by adminAdrianRamirez | Mar 8, 2017 | HempMeds Mexico, Press Releases, Scientific Research
Article Also Details Company’s Pioneering Role in Latin America’s Burgeoning Cannabis Market SAN DIEGO, March 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary HempMeds® Mexico, the first company to receive government...
by adminAdrianRamirez | Mar 7, 2017 | Axim Biotechnologies, Press Releases
NEW YORK, March 7, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and...
by adminAdrianRamirez | Mar 6, 2017 | HempMeds, Press Releases
SAN DIEGO, March 6, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is pleased to announce that the Company’s Chief Executive Officer Dr. Stuart Titus is a featured speaker at the California...
by adminAdrianRamirez | Mar 1, 2017 | Axim Biotechnologies, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Press Releases
SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol...
by adminAdrianRamirez | Mar 1, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 28, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s...
by adminAdrianRamirez | Feb 23, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Feb. 23, 2017 — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, Chief Executive Officer, Dr. Stuart Titus, recently participated in a much-anticipated A4M Mexico conference and was featured by...